Sjölander A. (In press). A cautionary note on extended Kaplan-Meier curves for time-varying covariates. Epidemiology.

Sachs MC, Sjölander A, Gabriel EE. (In press). Aim for clinical utility, not just predictive accuracy. Epidemiology.

Sjölander A. (In press). Estimation of marginal causal effects in the presence of confounding by cluster. Biostatistics.

Dahlqwist E, Kutalik Z, Sjölander A. (In press). Using instrumental variables to estimate the attributable fraction. Statistical Methods in Medical Research.

Sjölander A, Martinussen T. (In press). Instrumental variable estimation with the R package ivtools. Epidemiologic Methods.

Sjölander A, Vansteelandt S. (2019). Frequentist vs Bayesian frameworks for multiple testing. European Journal of Epidemiology 34(9), 809-821.

Zetterqvist J, Vermeulen K, Vansteelandt S, Sjölander A. (2019). Doubly robust conditional logistic regression. Statistics in Medicine 38(23), 4749-4760.

Dahlqwist E, Magnusson KEP, Pawitan Y, Sjölander A. (2019). On the relationship between the heritability and the attributable fraction. Human Genetics 138(4), 425-435.

Sjölander A, Ning Y. (2019). A general and robust estimation method for the case-time-control design. Sociological Methodology 49(1), 349-365.

Dahlqwist E, Pawitan Y, Sjölander A. (2019). Regression standardization and attributable fraction estimation with between-within frailty models for clustered survival data. Statistical Methods in Medical Research 28(2), 462-485.

Sjölander A. (2018). Mediation analysis with attributable fractions. Epidemiologic Methods 7(1).

Sjölander A. (2018). Estimation of causal effect measures with the R-package stdReg. European Journal of Epidemiology 33(9), 847-858.

Lee W, Sjölander A, Pawitan Y. (2018). Likelihood-based inference for bounds of causal parameters. Statistics in Medicine 37(30), 4695-4706.

Sjölander A, Zetterqvist J. (2017). Confounders, mediators or colliders – What types of shared covariates does the sibling comparison design control for? Epidemiology 28(4), 540-547.

Sjölander, A. (2017). The case-time-control method for non-binary exposures. Sociological Methodology 47(1), 182-211.

Sjölander A, Vansteelandt S. (2017). Doubly robust estimation of attributable fractions in survival analysis. Statistical Methods in Medical Research 26(2), 948-969.

Dahlqwist E, Zetterqvist J, Pawitan Y, Sjölander A. (2016). Model-based estimation of the attributable fraction for cross-section, case-control, and cohort studies with the R package AF. European Journal of Epidemiology 31(6), 575-582.

Vansteelandt S, Sjölander A. (2016). Revisiting g-estimation of the effect of a time-varying exposure subject to time-varying confounding. Epidemiologic Methods 5(1), 37-56.

Lee W, Sjölander A, Pawitan Y. (2016). A critical look at entropy-based gene-gene interaction measures. Genetic Epidemiology 40(5), 416-424.

Sjölander A. (2016). Regression standardization with the R package stdReg. European Journal of Epidemiology 31(6), 563-574.

Sjölander A, Frisell T, Kuja-Halkola R, Öberg S, Zetterqvist J. (2016). Carry-over effects in sibling comparison designs. Epidemiology 27(6), 852-858.

Sjölander A, Dahlqwist E, Zetterqvist J. (2016). A note on the non-collapsibility of rate differences and rate ratios. Epidemiology 27(3), 356-359.

Zetterqvist J, Vansteelandt S, Pawitan Y, Sjölander A. (2016). Doubly robust methods for handling confounding by cluster. Biostatistics 17(2), 264-276.

Sjölander A. (2016). A cautionary note on the use of attributable fractions in cohort studies. Statistical Methods in Medical Research. 25(6), 2434-2443.

Zetterqvist J, Sjölander A. (2015). Doubly robust estimation with the R package drgee. Epidemiologic Methods 4(1), 69-86.

Kennedy E, Sjölander A, Small D. (2015). Semiparametric causal inference in matched cohort studies. Biometrika 102(3), 739-746.

Sjölander A, Lee W, Källberg H, Pawitan Y. (2014). Bounds on sufficient-cause interactions. European Journal of Epidemiology 29(11), 813-820.

Sjölander A, Lee W, Källberg H, Pawitan Y. (2014). Bounds on causal interactions for binary outcomes. Biometrics 70(3), 500-505.

Sjölander A. (2013). Reducing mean squared error in the analysis of binary paired data. Epidemiologic Methods 2(1), 33–47.

Sjölander A, Greenland S. (2013). Ignoring the matching variables in cohort studies – when is it valid, and why? Statistics in Medicine 32(27), 4696-4708.

Sjölander A, Lichtenstein P, Larsson H, Pawitan Y. (2013). Between-within models for survival analysis. Statistics in Medicine 32(18), 3067-3076.

Orsini N, Bellocco R, Sjölander A. (2013). Doubly robust estimation in generalized linear models. The Stata Journal 13(1), 185-205.

Sjölander A, Bellocco R. (2013). Adjusting for confounding through the blocking of front-doors in longitudinal studies. Epidemiology, Biostatistics and Public Health 10(1), e8757 1-10.

Sjölander A, Johansson ALV, Lundholm C, Altman D, Almqvist C, Pawitan Y. (2012). Analysis of 1:1 matched cohort studies and twin studies, with binary exposures and binary outcomes. Statistical Science 27(3), 395–411.

Sjölander A, Frisell T, Öberg S. (2012). Causal interpretation of between-within models for twin research. Epidemiologic Methods 1(1), 217–237.

Frisell T, Öberg S, Kuja-Halkola R, Sjölander A. (2012). Sibling comparison designs: bias from non-shared confounders and measurement error. Epidemiology 23(5), 713-720.

Sjölander A. (2011). Estimation of attributable fractions using inverse probability weighting. Statistical Methods in Medical Research 20(4), 415-428.

Sjölander A, Vansteelandt S. (2010). Doubly robust estimation of attributable fractions. Biostatistics 12(1), 112-121.

Sjölander A, Vansteelandt S, Humphreys K. (2010). A principal stratification approach to assess the differences in prognosis between cancers caused by hormone replacement therapy and by other factors. The International Journal of Biostatistics Vol. 6 : Iss. 1, Article 20.

Sjölander A. (2009). Bounds on natural direct effects in the presence of confounded intermediate variables. Statistics in Medicine 28, 558-571.

Sjölander A, Humphreys K, Vansteelandt S, Bellocco R, Palmgren J. (2009). Sensitivity analysis for principal stratum direct effects, with an application to a study of physical activity and coronary heart disease. Biometrics 65(2), 514-520.

Sjölander A, Humphreys K, Palmgren J. (2007). On informative detection bias in screening studies. Statistics in Medicine 27, 2635-2650.

Sjölander A, Hössjer O, Werner Hartman L, Humphreys K. (2007). Fine mapping of disease genes using tagging SNPs. Annals of Human Genetics 71(6), 815-827.


Wernroth ML, Fall K, Svennblad B, Ludvigsson JF, Sjölander A, Almqvist C, Fall T. (In press). Early childhood antibiotic treatment for otitis media and other respiratory tract infections is associated with risk of type 1 diabetes: a nationwide population register-based study with sibling analysis. Diabetes Care.

Chang Z, Quinn PD, O’Reilly L, Sjölander A, Hur K, Gibbons R, Larsson H, D’Onofrio BM. (In press). Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts. Biological Psychiatry.

Shen Q, Jöud A, Schelin MEC, Sjölander A, Cao Y, Sparén P, Fall K, Czene K, Valdimarsdóttir U, Fang F. (In press). Psychiatric disorders and cardiovascular diseases during the diagnostic workup of potential breast cancer: a population-based cohort study in Skåne, Sweden. Breast Cancer Research.

Laureati P, Xu Y, Trevisan M, Schalin L, Bellocco R, Sood MM, Barany P, Sjölander A, Evans M, Carrero JJ. (In press). Initiation of sodium polystyrene sulfonate and associated adverse events; a nationwide healthcare-based analysis from the Swedish Renal Register. Nephrology Dialysis Transplantation.

Azam S, Eriksson M, Sjölander A, Hellgren R, Gabrielson M, Czene K, Hall P. (In press). Mammographic density change and risk of breast cancer. JNCI.

Azam S, Sjölander A, Eriksson M, Gabrielson M, Czene K, Hall P. (In press). Determinants of mammographic density change. JNCI Cancer Spectrum.

Rosenqvist MA, Sjölander A, Ystrom E, Larsson H, T Reichborn-Kjennerud. (2019). Adverse family life events during pregnancy and ADHD symptoms in five year old offspring. Journal of Child Psychology and Psychiatry 60(6), 665-675.

Bokenberger K, Sjölander A, Dahl Aslan AK, Karlsson IK, Åkerstedt T, Pedersen NL. (2018). Shift Work and Risk of Incident Dementia: A study of two population-based cohorts. European Journal of Epidemiology 33(10), 977-987.

Chen R , Wallin AR, Selinus EN, Sjölander A, Fall K, Valdimarsdóttir U, Czene K, Fang F. (2018). Psychiatric disorders among children with parental cancer: a Swedish register-based matched cohort study. Psycho-Oncology 27(7), 1854-1860.

Zhu J, Sjölander A, Fall K, Valdimarsdottir U, Fang F. (2018). Mental disorders around cancer diagnosis and increased hospital admission rate – a nationwide cohort study of Swedish cancer patients. BMC Cancer 18(1), 322.

Song J, Kuja-Halkola R, Sjölander A, Bergen SE, Larsson H, Landén M, Lichtenstein P. Specificity in etiology of subtypes of bipolar disorder: Evidence from a Swedish population-based family study. (2018). Biological Psychiatry 84(11), 810-816.

Lantz M, Sieurin J, Sjölander A, Waldenlind E,  Sjöstrand C, Wirdefeldt K. (2017). Migraine and risk of stroke: a national population-based twin study. Brain 140(10), 2653-2662

Sjörs C, Hedenus F, Sjölander A, Tillander A, Bälter K. (2017). Adherence to dietary recommendations for Swedish adults across categories of greenhouse gas emissions from food. Public Health Nutrition 20(18), 3381-3393.

Lu Y, Sjölander A, Cederlöf M, D’Onofrio BM, Almqvist C, Larsson H, Lichtenstein P. (2017). Association between medication use and performance on higher education entrance tests in individuals with attention-deficit/hyperactivity disorder. JAMA Psychiatry 74(8), 815-822.

Zhu J, Fang F, Sjölander A, Fall K, Adami HO, Valdimarsdóttir U. (2017). First-onset mental disorders after cancer diagnosis and cancer-specific mortality: A nationwide cohort study. Annals of Oncology 28(8), 1964-1969.

Song J, Sjölander A, Joas E, Bergen SE, Runeson B, Larsson H, Landén M, Lichtenstein P. (2017). Suicidal behavior during lithium and valproate medication: a within-individual eight year prospective study of 50,000 patients with bipolar disorder. The American Journal of Psychiatry 174(8), 795-802.

Quinn PD, Chang Z, Hur K, Gibbons RD, Lahey BB, Rickert ME, Sjölander A, Lichtenstein P, Larsson H, D’Onofrio BM. (2017). Attention-deficit/hyperactivity disorder medication and substance-related problems.  The American Journal of Psychiatry 174(9), 877-885.

Gong T, Brew B, Sjölander A, Almqvist C. (2017). Towards non-conventional methods of designing register-based epidemiological studies: an application to pediatric research. Scandinavian Journal of Public Health 45(17_suppl),

Chang Z, Quinn PD, Hur K, Gibbons RD, Sjölander A, Larsson H, D’Onofrio BM. (2017). Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry 74(6), 597-603.

Bälter K, Sjörs C, Sjölander A, Gardner C, Hedenus F, Tillander A. (2017). Is a diet low in greenhouse gas emissions a nutritious diet? Archives of Public Health 75, 17.

Chen Q, Kuja-Halkola R, Sjölander A, Serlachius E, Cortese S, Faraone SV, Almqvist C, Larsson H. (2017). Shared familial risk factors between attention-deficit/hyperactivity disorder and overweight/obesity – a population based familial co-aggregation study in Sweden.  Journal of Child Psychology and Psychiatry 58(6), 711-718.

Cederlöf M, Kuja-Halkola R, Larsson H, Sjölander A, Östberg P, Lundström S, Anckarsäter H, Kelleher I, Lichtenstein P. (2017). A longitudinal study of adolescent psychotic experiences and later development of substance use disorder and suicidal behavior. Schizophrenia Research 181, 13-16.

Evans M, Carrero J-J, Bellocco R, Barany P, Qureshi AR, Seeberger A, Jacobson SH, Hylander B, Rotnitzky A, Sjölander A. (2017). Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anemic chronic kidney disease patients. Nephrology Dialysis Transplantation 32(11), 1892-1901.

Cesta CE, Viktorin A, Olsson H, Johansson V, Sjölander A, Bergh C, Skalkidou A, Nygren K-G, Cnattingius S, Iliadou AN. (2016). Depression, anxiety, and antidepressant treatment in women:  association with in-vitro fertilization outcome. Fertility and Sterility 105(6), 1594-1602.

Bonn SE, Sjölander A, Tillander A, Wiklund F, Grönberg H, Bälter K. (2016). Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk. International Journal of Cancer 139(1), 50-57.

Sjörs C, Raposo SE, Sjölander A, Bälter O, Hedenus F, Bälter K. (2016). Diet-related greenhouse gas emissions assessed by a food frequency questionnaire and validated using 7-day weighed food records. Environmental Health 15(1), 15.

Lu D, Sundström K, Sparén P, Fall K, Sjölander A, Dillner J, Helm NY,  Adami HO, Valdimarsdóttir U, Fang F. (2016). Bereavement is associated with an increased risk of HPV infection and cervical cancer: an epidemiological study in Sweden. Cancer Research 76(3), 643-651.

D’Onofrio BM, Class QA, Rickert ME, Sujan AC, Larsson H, Kuja-Halkola R, Sjölander A, Almqvist C, Lichtenstein P, Öberg AS. (2016). Translational epidemiologic approaches to understanding the consequences of early-life exposures. Behavior Genetics 46(3), 315-328.

Yao S, Kuja-Halkola R, Thornton LM, Runfola CD, D’Onofrio BM, Almqvist C, Lichtenstein P, Sjölander A, Larsson H, Bulik CM. (2016). Familial Liability for Eating Disorders and Suicide Attempts: A Population-Based Study in Sweden. JAMA Psychiatry 73(3), 284-291.

Sujan AC, Rickert ME, Class QA, Coyne CA, Lichtenstein P, Almqvist C, Larsson H, Sjölander A, Lahey, BB, van Hulle C, Waldman I, Öberg SA,  D’Onofrio BM. (2016). A genetically informed study of the associations between maternal age at childbearing and adverse perinatal outcomes. Behavior Genetics 46(3), 431-456.

Chen R, Wallin AR, Sjölander A, Valdimarsdóttir U, Ye W, Tiemeier H, Fall K, Almqvist C, Czene K, Fang F. (2015). Childhood injury after a parental cancer diagnosis. eLife 31(4), e08500.

Bonn SE, Bergman P, Lagerros YT, Sjölander A, Bälter K. (2015). A validation study of the web-based physical activity questionnaire Active-Q against the GENEA accelerometer.  JMIR Research Protocols 4(3), e86.

Trinh T, Christensen S, Brand J, Cuzick J, Czene K, Sjölander A, Bälter K, Hall P. (2015). Background risk of breast cancer influences the association between alcohol consumption and mammographic density. British Journal of Cancer 113(1), 159-165.

Trinh T, Eriksson M, Darabi H, Bonn SE, Brand JS, Cuzick J, Czene K, Sjölander A, Bälter K, Hall P. (2015). Background risk of breast cancer and the association between physical activity and mammographic density. Breast Cancer Research 17(1), 50.

Chen R, Sjölander A, Valdimarsdóttir U, Varnum C, Almqvist C, Ye W, Fall K, Czene K, Fang F. (2015). Parental cancer diagnosis and child mortality – a population-based cohort study in Sweden. Cancer Epidemiology 39(1), 79-85.

Bonn SE, Sjölander A, Lagerros YT, Wiklund F, Stattin P, Holmberg P, Grönberg H, Bälter K. (2015). Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiology, Biomarkers and Prevention 24(1), 57-64.

Hallböök T, Sjölander A, Åmark P, Miranda M, Bjurulf B, Dahlin M. (2015). Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia. European Journal of Paediatric Neurology 19(1), 29-36.

Chang Z, Lichtenstein P, D’Onofrio BM, Almqvist C, Kuja-Halkola R, Sjölander A, Larsson H. (2014). Maternal age at childbirth and risk for ADHD in offspring: A population-based cohort study. International Journal of Epidemiology 43(6), 1815-1824.

Sjörs C, Bonn S, Lagerros YT, Sjölander A, Bälter K. (2014). Perceived reasons, incentives, and barriers to physical activity in Swedish elderly men. Interactive Journal of Medical Research 3(4), e15.

Cederlöf M, Bergen SE, Långstrom N, Larsson H, Boman M, Craddock N, Östberg P, Lundström S, Sjölander A, Nordlind K, Landén M, Lichtenstein P. (2014). The association between Darier disease, bipolar disorder and schizophrenia revisited: a population-based family study. Bipolar Disorders 17(3), 340-344.

Pettersson E, Sjölander A, Almqvist C, Anckarsäter H, D’Onofrio BM, Lichtenstein P, Larsson H. (2014). Birth weight as an independent predictor of ADHD symptoms: A within-twin pair analysis. Journal of Child Psychology and Psychiatry 56(4), 453-459.

Chen Q, Sjölander A, Runeson B, D’Onofrio BM, Lichtenstein P, Larsson H. (2014). Drug treatment for Attention-Deficit/Hyperactivity Disorder and suicidal behavior: register based study. BMJ. DOI: 10.1136/bmj.g3769

Bonn SE, Wiklund F, Sjölander A, Szulkin R, Stattin P, Holmberg E, Grönberg H, Bälter K. (2014). Body mass index and weight change in men with prostate cancer: progression and mortality. Cancer Causes and Control 25(8), 933-943.

D’Onofrio BM, Rickert ME, Frans E, Kuja-Halkola R, Almqvist C, Sjölander A, Larsson H, Lichtenstein P. (2014). Paternal age at childbearing and offspring psychiatric and academic morbidity. JAMA Psychiatry 71(4), 432-438.

Chang Z, Lichtenstein P, D’Onofrio BM, Sjölander A, Larsson H. (2014). Serious transport accidents in adults with ADHD, and the effect of medication: A population based study. JAMA Psychiatry 71(3), 319-325.

Chen Q, Sjölander A, Långström N, Rodriguez A, Serlachius E, D’Onofrio BM, Lichtenstein P, Larsson H. (2014). Maternal pre-pregnancy body mass index and offspring Attention-Deficit/Hyperactivity Disorder: a population based cohort study using a sibling-comparison design. The International Journal of Epidemiology 43(1), 83-90.

Christensen SE, Möller E, Bonn S, Ploner A, Wright A, Sjölander A, Bälter O, Lissner L, Bälter K. (2013). Two new meal- and web-based food frequency questionaires: validation of energy and macronutrient intake. Journal of Medical Internet Research 15(6):e109.

Lichtenstein P, Halldner L, Zetterqvist J, Sjölander A, Serlachius E, Fazel S, Långström N, Larsson H. (2012). Medication for attention deficit-hyperactivity disorder and criminality. New England Journal of Medicine 367(21), 2006-2014.

Bonn S, Lagerros YT, Christensen S, Möller E, Wright A, Sjölander A, Bälter KA. (2011). Active Q: Validation of the web-based physical activity questionnaire using doubly labeled water. Journal of Medical Internet Research 14(1), e29.

Sjölander A, Nyren O, Bellocco R, Evans M. (2011). Comparing different strategies for timing of dialysis initiation through inverse probability weighting. American Journal of Epidemiology 174(10), 1204-1210.

Einarsdottir K, Darabi H, Li Y, Low YL, Li, YQ, Bonnard C, Sjölander A, Czene K, Wedren S, Liu, ET, Hall P, Humphreys K, Liu J. (2008). ESR1 and EGF genetic varitation in relation to breast cancer risk and survival. Breast Cancer Research 10(1):R15.

Einarsdottir K, Humphreys K, Bonnard C, Palmgren J, Iles MM, Sjölander A, Li Y, Chia KS, Liu ET, Hall P, Liu J and Wedren S (2006). Linkage disequilibrium mapping of CHECK2: Common variation and breast cancer risk. PLoS Medicine 3(6), e168.

Book chapters

Sjölander A. (2018). Kvantitativa studier: Sambands validitet och reliabilitet. In Grunderna för ett vetenskapligt förhållningssätt inom medicinen, Nyrén O, Garwics M, Nilsson K, Shoshan M (eds), Liber.

Sjölander A. (2016). Attributable fractions. Wiley StatsRef: Statistics Reference Online. 1-7.

Sjölander A, Lindkvist G. (2014). Betydelsen av ursprungssannolikhet vid bevisvärdemetoden. In Festskrift till Christian Diesen, Andersson S, Lainpelto K (eds), Norstedts Juridik.

Sjölander A. (2011). Cross-classifications by joint potential outcomes. In Causal Inference: Statistical Perspectives and Applications, Berzuini C, Dawid P, Bernadinell L (eds), Wiley.

Sjölander A. (2011). The language of potential outcomes. In Causal Inference: Statistical Perspectives and Applications, Berzuini C, Dawid P, Bernadinell L (eds), Wiley.

Sjölander A, Vansteelandt S. (2009). Marginal structural models. In The Encyclopaedic Companion to Medical Statistics, Everitt BS, Palmer C (eds.), Wiley

Short communications

Sjölander A, Vansteelandt S. (In press). Authors’ reply to “Multiple comparisons controversies are about context and costs, not frequentism vs. Bayesianism”. European Journal of Epidemiology.

Sjölander A. (In press). An approximate expression for the proportion explained by mediation in survival analysis. Epidemiology.

Ludvigsson JF, Sjölander A, Murray JA, Hjalgrim H, Edgren G. (In press), Hemoglobin decline before celiac disease diagnosis – a nationwide transfusion cohort study of 1.1 million blood donors. Gut.

D’Onofrio BM, Sjölander A, Lichtenstein P. (2014). Fixed effects models and diagnosing psychiatric disorders – reply. JAMA Psychiatry 71(9), 1078-1079.

Pawitan Y, Sjölander A. (2014). Dealing with multiple comparisons: To adjust or not to adjust. Qvintensen 2, 11-14.

Sjölander A. (2013). Klarlägganden om mendelsk randomisering. Läkartidningen, 110: CCEU.

Sjölander A. (2011). Reaction to Pearl’s critique of principal stratification (Invited commentary of “Principal stratification – a goal or a tool?”). International Journal of Biostatistics 7(1), Article 22.

Sjölander A. (2009). Propensity scores and M-structures. Statistics in Medicine 28(9), 1416-1420.

Sjölander A. (2009). Comments on `Formulating the tightest bounds on causal effects in studies with unmeasured confounders’, by Kuroki and Cai. Statistics in Medicine 28(11), 1636-1638.

Sjölander A. (2008). A note on the method of handling non-compliance in clinical trials suggested by Sato/Matsuyama. Statistics in Medicine 27(19), 3920-3924.